Dashboard
Manage Tickers

ABTABBOTT LABORATORIES

NYSE abbott.com


$ 105.28 $ -0.63 (-0.59 %)    

Thursday, 18-Apr-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 422.80 $ -4.11 (-0.96 %)
DIA $ 377.76 $ 0.39 (0.1 %)
SPY $ 499.54 $ -2.16 (-0.43 %)
TLT $ 88.82 $ -0.46 (-0.52 %)
GLD $ 220.32 $ 0.73 (0.33 %)
$ 105.27
$ 106.32
$ 0.00 x 0
$ 0.00 x 0
$ 104.49 - $ 107.02
$ 88.80 - $ 121.04
7,294,151
na
184.12B
$ 0.77
$ 32.17
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-16-2024 12-31-2023 10-K
2 11-01-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-17-2023 12-31-2022 10-K
6 11-01-2022 09-30-2022 10-Q
7 08-02-2022 06-30-2022 10-Q
8 05-03-2022 03-31-2022 10-Q
9 02-18-2022 12-31-2021 10-K
10 11-03-2021 09-30-2021 10-Q
11 08-04-2021 06-30-2021 10-Q
12 05-05-2021 03-31-2021 10-Q
13 02-19-2021 12-31-2020 10-K
14 11-04-2020 09-30-2020 10-Q
15 07-29-2020 06-30-2020 10-Q
16 04-29-2020 03-31-2020 10-Q
17 02-21-2020 12-31-2019 10-K
18 10-31-2019 09-30-2019 10-Q
19 07-31-2019 06-30-2019 10-Q
20 05-01-2019 03-31-2019 10-Q
21 02-22-2019 12-31-2018 10-K
22 10-31-2018 09-30-2018 10-Q
23 08-01-2018 06-30-2018 10-Q
24 05-02-2018 03-31-2018 10-Q
25 02-16-2018 12-31-2017 10-K
26 11-02-2017 09-30-2017 10-Q
27 08-02-2017 06-30-2017 10-Q
28 05-03-2017 03-31-2017 10-Q
29 02-17-2017 12-31-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-03-2016 06-30-2016 10-Q
32 05-04-2016 03-31-2016 10-Q
33 02-19-2016 12-31-2015 10-K
34 11-05-2015 09-30-2015 10-Q
35 08-04-2015 06-30-2015 10-Q
36 05-06-2015 03-31-2015 10-Q
37 02-27-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-05-2014 06-30-2014 10-Q
40 05-07-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

behind-the-scenes-of-abbott-laboratoriess-latest-options-trends
Behind the Scenes of Abbott Laboratories's...
04/18/2024 17:31:58

rbc-capital-maintains-outperform-on-abbott-laboratories-lowers-price-target-to-125
RBC Capital Maintains Outperform on Abbott...
04/18/2024 15:54:14

RBC Capital analyst Shagun Singh maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price target from...

stocks-fall-as-geopolitics-economic-worries-spook-investors-chipmakers-sell-off-bitcoin-tumbles-to-60000-whats-driving-markets-wednesday
Stocks Fall As Geopolitics, Economic Worri...
04/17/2024 18:09:39

A sentiment of risk aversion looms over the markets during Wednesday’s trading session, triggering midday losses across the boa...

dow-surges-200-points-abbott-laboratories-posts-upbeat-earnings
Dow Surges 200 Points; Abbott Laboratories...
04/17/2024 14:07:53

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market ...

abbott-labs-q1-revenue-jumps-on-strong-medical-devices-sales-company-boosts-annual-guidance
Abbott Labs Q1 Revenue Jumps On Strong Med...
04/17/2024 12:42:16

Abbott Laboratories surpasses expectations with Q1 sales hitting $9.96B, a 10.8% rise driven by robust performance in Medical D...

abbott-forecasts-q2-2024-adjusted-eps-of-108-112-versus-consensus-of-112
Abbott Forecasts Q2 2024 Adjusted EPS Of $...
04/17/2024 11:37:50

abbott-revises-2024-adjusted-eps-guidance-to-455-470-versus-prior-guidance-of-450-470-and-consensus-of-462
Abbott Revises 2024 Adjusted EPS Guidance ...
04/17/2024 11:36:44

abbott-laboratories-q1-2024-adj-eps-098-beats-095-estimate-sales-9964b-beat-9880b-estimate
Abbott Laboratories Q1 2024 Adj EPS $0.98 ...
04/17/2024 11:32:10

Abbott Laboratories (NYSE:ABT) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.9...

wall-street-poised-to-rebound-from-slump-as-earnings-optimism-grows-analyst-eyes-this-sp-500-level-as-attractive-entry-point
Wall Street Poised To Rebound From Slump A...
04/17/2024 11:09:02

U.S. stocks are priming for a firmer start on Wednesday, potentially striving to inflect higher from the weakness seen so far i...

earnings-scheduled-for-april-17-2024
Earnings Scheduled For April 17, 2024
04/17/2024 09:15:11

Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is projected to report quarterly earnings at $3.43 per share ...

investor-optimism-decreases-dow-ends-6-session-losing-streak
Investor Optimism Decreases; Dow Ends 6-Se...
04/17/2024 06:06:33

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index remaining in the "Fear&...

abbott-laboratories-us-bancorp-and-3-stocks-to-watch-heading-into-wednesday
Abbott Laboratories, U.S. Bancorp And 3 St...
04/17/2024 06:06:22

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as ...

abbottthoratec-corp-recalls-heartmate-ii-and-heartmate-3-left-ventricular-assist-system-due-to-long-term-buildup-causing-an-obstruction
Abbott/Thoratec Corp. Recalls HeartMate II...
04/15/2024 15:26:17

Please be aware, this recall is a correction, not a product removal.The FDA has identified this as a Class I recall, the most s...

jim-cramer-calls-cummins-terrific-recommends-selling-this-chinese-auto-manufacturer
Jim Cramer Calls Cummins 'Terrific,' Recom...
04/12/2024 12:43:01

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc.

abbott-laboratories-unusual-options-activity
Abbott Laboratories Unusual Options Activity
04/11/2024 18:31:13

jim-cramer-was-upset-at-this-hostile-takeover-but-they-fixed-the-situation-stocks-been-a-horse
Jim Cramer Was Upset At This Hostile Takeo...
04/09/2024 13:10:29

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over

evercore-isi-group-maintains-outperform-on-abbott-laboratories-raises-price-target-to-125
Evercore ISI Group Maintains Outperform on...
04/04/2024 16:18:39

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price targe...

analyst-ratings-for-abbott-laboratories
Analyst Ratings For Abbott Laboratories
04/03/2024 16:00:23

citigroup-maintains-buy-on-abbott-laboratories-raises-price-target-to-128
Citigroup Maintains Buy on Abbott Laborato...
04/03/2024 15:32:37

Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $126 t...

fda-approves-abbotts-heart-valve-repair-device-for-patients-at-risk-of-complicationsdeath-during-open-heart-surgeries
FDA Approves Abbott's Heart Valve Repair D...
04/02/2024 17:00:12

FDA approves Abbott Laboratories' TriClip TEER system for treating tricuspid regurgitation. Clip technology offers non-inva...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)